• Users Online: 505
  • Print this page
  • Email this page
Year : 2021  |  Volume : 1  |  Issue : 3  |  Page : 522-523

New-onset anterior uveitis in two patients on ustekinumab for inflammatory bowel disease

Department of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts, United States

Correspondence Address:
Dr. Kara C LaMattina
Department of Ophthalmology, Boston University School of Medicine, 85 East Concord Street, 8th Floor, Boston, MA 02118
United States
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijo.IJO_3248_20

Rights and Permissions

This report presents the first published cases of new-onset uveitis in patients on ustekinumab therapy. We present two patients with inflammatory bowel disease who developed anterior uveitis while on ustekinumab 90 mg every 8 weeks. Both patients achieved quiescence of their uveitis and improved control of their systemic disease with increased dose frequency of ustekinumab at every 4 weeks. Further investigation is warranted to determine if a true association exists.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded17    
    Comments [Add]    

Recommend this journal